Gene Panel Predicts Response to Crucial Breast Cancer Therapy
Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by ...
Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by ...
In the relentless quest for novel cancer therapies, a potent class of compounds known as stilbenes has recently captured the ...
In a striking development that has sent ripples through the oncology research community, a recent study investigating the cytotoxic effects ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled compelling evidence positioning E2F transcription factor 2 (E2F2) as ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine